Statistics for DIA.PRO

8Total Devices

7Basic UDI-DIs

0Not destined for EU market

0Certificates

0Valid

0Expiring < 6 months

2Countries

Certificate health for DIA.PRO

No certificates registered for this manufacturer.

Devices by risk class

Device catalog for DIA.PRO

Showing 1–8 of 8 devices.

Trade name	Reference / catalog number	UDI-DI code	Quantity	Status
Dengue virus NS1 Ag	`DENS1AG.CE`	`08050616042262`	1	On the market
DP5	`DP5`	`08050616042729`	1	On the market
HEV IgM	`EVM.CE`	`08050616040183`	1	On the market
SARA_Gen2	`SARA_Gen2`	`08050616042767`	1	On the market
Parvovirus B19 IgM	`PARVOM.CE`	`08050616041036`	1	On the market
SARA	`S.A.R.A.`	`08050616042033`	1	On the market
SYPH IgM	`SIM.CE`	`08050616040909`	1	On the market
ZIKV IgM	`ZIKVM.CE`	`08050616041081`	1	On the market

Device families (Basic UDI-DI) of DIA.PRO

Showing 1–7 of 7 device families.

Market presence of DIA.PRO

Devices placed in 2 countries

Italy7
Bulgaria1

EUDAMED update: Mar 3, 2026

DIA.PRO DIAGNOSTIC BIOPROBES S.R.L.

IT-MF-000029123

Active

Address: VIA G. CARDUCCI , 27 20099 SESTO SAN GIOVANNI (MILANO)
Role: Manufacturer
Date of registration: Oct 4, 2022
Country: IT Italy

About DIA.PRO

SRN: IT-MF-000029123
Role: Manufacturer
Country: Italy
Organization name: DIA.PRO DIAGNOSTIC BIOPROBES S.R.L.
EU VAT number: 11924660159
EORI: IT11924660159
Trade register: 11924660159
Date of registration: Oct 4, 2022

Contact details for DIA.PRO

Address: 27, VIA G. CARDUCCI 20099 SESTO SAN GIOVANNI (MILANO) ITALY
Phone: +390227007161
Email: info@diapro.it
Website: www.diapro.it

Validator

Name: Ministero della salute - Direzione generale dei dispositivi medici e del servizio farmaceutico
SRN: IT-CA-070
Phone: +39 06 5994 3199/ +39 06 5994 3207
Email: segr.dgfdm@sanita.it

Officers and regulatory representatives of DIA.PRO

RUSSO Dario
Regulatory Compliance of DIA.PRO IVDD, ensuring that their conformity is checked, according to the QMS. Ensuring that the technical documentation and DoC of DIA.PRO IVDD are drawn up updated and maintained; that the PMS obligations are fulfilled; that the reporting obligations referred to in Articles 82 to 86 of IVDR are fulfilled; that in case of devices intended to be used for interventional clinical performance studies the declaration referred to in Annex XIV, point 4.1 of IVDR is issued.
Hidden

Become a partner of MD Atlas